Literature DB >> 27335370

Warburg effect linked to cognitive-executive deficits in FMR1 premutation.

Eleonora Napoli1, Gyu Song1, Andrea Schneider2, Randi Hagerman2, Marwa Abd Al Azaim Eldeeb3, Atoosa Azarang3, Flora Tassone4, Cecilia Giulivi5.   

Abstract

A 55-200 CGG repeat expansion in the 5'-UTR of the fragile X mental retardation 1 (FMR1) gene is known as a premutation. Some carriers are affected by the neurodegenerative disorder fragile X-associated tremor/ataxia syndrome (FXTAS), primary ovarian insufficiency, and neurobehavioral impairments. Based on the mitochondrial dysfunction observed in fibroblasts and brain samples from carriers, as well as in neurons and brains from a mouse model of the premutation, we evaluated the presence of the Warburg effect in peripheral blood mononuclear cells (PBMCs) from 30 premutation carriers with either a rebalance of the metabolism [increasing glycolysis while decreasing oxidative phosphorylation (oxphos)] or a metabolic amplification (increasing glycolysis while maintaining/increasing oxphos). Deficits in oxphos-more pronounced in FXTAS-affected subjects-were accompanied by a shift toward glycolysis, suggesting increased glycolysis despite aerobic conditions. Differential proteomics extended these findings, unveiling a decreased antioxidant response, translation, and disrupted extracellular matrix and cytoskeleton organization with activation of prosenescence pathways. Lower bioenergetics segregated with increased incidence of low executive function, tremors, below-average IQ, and FXTAS. The combination of functional and proteomic data unveiled new mechanisms related to energy production in the premutation, showing the potential of being applicable to other psychiatric disorders to identify endophenotype-specific responses relevant to neurobiology.-Napoli, E., Song, G., Schneider, A., Hagerman, R., Eldeeb, M. A. A. A., Azarang, A., Tassone, F., Giulivi, C. Warburg effect linked to cognitive-executive deficits in FMR1 premutation. © FASEB.

Entities:  

Keywords:  fragile X; mitochondria; neurological disorder; proteomics; triplet nucleotide diseases

Mesh:

Substances:

Year:  2016        PMID: 27335370      PMCID: PMC5024697          DOI: 10.1096/fj.201600315R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  95 in total

Review 1.  Uncoupling proteins: the issues from a biochemist point of view.

Authors:  M Klingenberg; K S Echtay
Journal:  Biochim Biophys Acta       Date:  2001-03-01

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

4.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

Review 6.  Mitochondrial uncoupling proteins in the CNS: in support of function and survival.

Authors:  Zane B Andrews; Sabrina Diano; Tamas L Horvath
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

Review 7.  Mitochondrial dysfunction and migraine: evidence and hypotheses.

Authors:  M Sparaco; M Feleppa; R B Lipton; A M Rapoport; M E Bigal
Journal:  Cephalalgia       Date:  2006-04       Impact factor: 6.292

8.  The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues.

Authors:  Daniela Fornuskova; Olga Brantova; Marketa Tesarova; Lukas Stiburek; Tomas Honzik; Laszlo Wenchich; Evzenie Tietzeova; Hana Hansikova; Jiri Zeman
Journal:  Biochim Biophys Acta       Date:  2008-02-15

9.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

10.  Identification of brain transcriptional variation reproduced in peripheral blood: an approach for mapping brain expression traits.

Authors:  Anna J Jasinska; Susan Service; Oi-wa Choi; Joseph DeYoung; Olivera Grujic; Sit-yee Kong; Matthew J Jorgensen; Julia Bailey; Sherry Breidenthal; Lynn A Fairbanks; Roger P Woods; J David Jentsch; Nelson B Freimer
Journal:  Hum Mol Genet       Date:  2009-08-19       Impact factor: 6.150

View more
  18 in total

1.  Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.

Authors:  Gaëlle Robin; José R López; Glenda M Espinal; Susan Hulsizer; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

2.  Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation.

Authors:  Cecilia Giulivi; Eleonora Napoli; Flora Tassone; Julian Halmai; Randi Hagerman
Journal:  Biochem J       Date:  2016-08-23       Impact factor: 3.857

Review 3.  Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions.

Authors:  Zhi-Dong Zhou; Joseph Jankovic; Tetsuo Ashizawa; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2022-01-12       Impact factor: 44.711

4.  May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells.

Authors:  Cesar V Borlongan; Hung Nguyen; Trenton Lippert; Eleonora Russo; Julian Tuazon; Kaya Xu; Jea-Young Lee; Paul R Sanberg; Yuji Kaneko; Eleonora Napoli
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-30       Impact factor: 6.200

5.  Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Emily J Hill; Christopher G Goetz; Glenn T Stebbins; Randi Hagerman; Bichun Ouyang; Deborah A Hall
Journal:  Mov Disord Clin Pract       Date:  2020-03-04

6.  Wdfy3 regulates glycophagy, mitophagy, and synaptic plasticity.

Authors:  Eleonora Napoli; Alexios A Panoutsopoulos; Patricia Kysar; Nathaniel Satriya; Kira Sterling; Bradley Shibata; Denise Imai; David N Ruskin; Konstantinos S Zarbalis; Cecilia Giulivi
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-29       Impact factor: 6.960

7.  Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins.

Authors:  Eleonora Napoli; Andrea Schneider; Randi Hagerman; Gyu Song; Sarah Wong; Flora Tassone; Cecilia Giulivi
Journal:  Front Genet       Date:  2018-08-27       Impact factor: 4.599

8.  Deficits in Prenatal Serine Biosynthesis Underlie the Mitochondrial Dysfunction Associated with the Autism-Linked FMR1 Gene.

Authors:  Sarah L Nolin; Eleonora Napoli; Amanda Flores; Randi J Hagerman; Cecilia Giulivi
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

9.  Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.

Authors:  Eleonora Napoli; Amanda Flores; Yasmeen Mansuri; Randi J Hagerman; Cecilia Giulivi
Journal:  Neurobiol Dis       Date:  2021-06-19       Impact factor: 7.046

10.  Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.

Authors:  Cecilia Giulivi; Eleonora Napoli; Flora Tassone; Julian Halmai; Randi Hagerman
Journal:  Front Mol Neurosci       Date:  2016-08-12       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.